S

Sionna Therapeutics

29 employees

Sionna Therapeutics is developing novel small molecule therapies to treat cystic fibrosis (CF).

Basic info

Industry

biotechnology research

Sectors

Biotechnology
orphan disease
small molecule
biotechnology
rare disease
genetic mutation
protein function
research
genetics
molecular engineering
cystic fibrosis
Genetics
life sciences
genetic disease
chemistry
clinical study
patient advocacy
drug development
Pharmaceutical
pharmaceuticals
lung
Health Care
clinical research
Therapeutics
clinical development
Medical

Date founded

2019

Funding rounds raised

Total raised

$110M

from 4 investors over 4 rounds

S

Sionna Therapeutics raised $110M on April 19, 2022

Investors: OrbiMed Advisors, RA Capital Management, L.P., Atlas Venture and T. Rowe Price

FAQ